Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	17890.33	54602.50	-303.51
Graham Fair Price	22.45	715.53	584.35
PEG	-30.08	0.28	-0.41
Price/Book	22.44	0.78	0.64
Price/Cash Flow	inf	0.00	87.18
Prices/Earnings	-9.41	12.02	13.27
Price/Sales	-3.70	8.92	9.27
Price/FCF	inf	0.00	87.18
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	9.00	0.27	0.25
ROA	37.96	< 0.005	< 0.005
ROE	0.01	0.02	35.16
ROIC	< 0.005	< 0.005	65.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.59	-0.01	4638.91
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.33	0.45	38.98
EPS QOQ	-0.33	0.42	29.57
FCF QOQ	< 0.005	-1.00	10990.70
Revenue QOQ	-0.06	0.33	419.18
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.78	0.73	-6.31
Quick Ratio	0.37	6.53	1663.77
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1124.17	1184.04	5.33
Cash	8542.57	8895.04	4.13
Capex	0.00	0.00	0.00
Free Cash Flow	8.22	0.00	inf
Revenue	77.32	103.54	33.92
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.37	7.01	1795.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-340.90	65214.48	19030.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating